This plan benefits those with significant weight loss goals (40+ pounds) or individuals seeking complete lifestyle transformation
The researchers noted that compared with the control group, the epithalamin-treated patients exhibited [10]: Decelerated aging of the cardiovascular system Decreased rate of cardiovascular mortality and cardiovascular failure (-50%) Less age-associated impairment of physical endurance Normalized circadian rhythm for melatonin production Normalized circadian rhythm for lipid (fats) and carbohydrate metabolism Lower rate of mortality (-28%) The follow-up study on long-term epithalamin treatment represents strong evidence of eptithalons favorable safety profile and relative absence of notable epithalon side effects
Addressing side effects is not just about comfort
Lastly, drug manufacturers are also studying the use of GLP-1s for the treatment of cardiovascular disease, as well as several other diseases that are often co-morbidities with diabetes (including heart failure, peripheral arterial disease, sleep apnea, and diabetic retinopathy)
Robijn, S., Hoppe, B., Vervaet, B
While these medications have been around for nearly 20 years for diabetes, they only recently became popularized as a tool for managing appetite and promoting weight loss
